These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33685597)

  • 1. Mitochondrial DNA modification by CRISPR/Cas system: Challenges and future direction.
    Prakash R; Kannan A
    Prog Mol Biol Transl Sci; 2021; 178():193-211. PubMed ID: 33685597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections.
    Wahid B; Usman S; Ali A; Saleem K; Rafique S; Naz Z; Ahsan Ashfaq H; Idrees M
    Viral Immunol; 2017 Oct; 30(8):552-559. PubMed ID: 28825529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Mitochondrial Genome Editing by CRISPR/Cas9.
    Jo A; Ham S; Lee GH; Lee YI; Kim S; Lee YS; Shin JH; Lee Y
    Biomed Res Int; 2015; 2015():305716. PubMed ID: 26448933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knock-In Strategy for Editing Human and Zebrafish Mitochondrial DNA Using Mito-CRISPR/Cas9 System.
    Bian WP; Chen YL; Luo JJ; Wang C; Xie SL; Pei DS
    ACS Synth Biol; 2019 Apr; 8(4):621-632. PubMed ID: 30955321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.
    Koujah L; Shukla D; Naqvi AR
    Semin Cell Dev Biol; 2019 Dec; 96():53-64. PubMed ID: 30953741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-mediated mutagenesis at microhomologous regions of human mitochondrial genome.
    Wang B; Lv X; Wang Y; Wang Z; Liu Q; Lu B; Liu Y; Gu F
    Sci China Life Sci; 2021 Sep; 64(9):1463-1472. PubMed ID: 33420919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications.
    Bhatia S; Pooja ; Yadav SK
    Int J Biol Macromol; 2023 May; 238():124054. PubMed ID: 36933595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
    Li X; Shi W; Geng LZ; Xu JP
    Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short overview of CRISPR-Cas technology and its application in viral disease control.
    Ghorbani A; Hadifar S; Salari R; Izadpanah K; Burmistrz M; Afsharifar A; Eskandari MH; Niazi A; Denes CE; Neely GG
    Transgenic Res; 2021 Jun; 30(3):221-238. PubMed ID: 33830423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editing the Mitochondrial Genome: No CRISPR Required.
    Riepsaame J
    Trends Genet; 2020 Nov; 36(11):809-810. PubMed ID: 32819722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas based genome editing for eradication of human viruses.
    Solanki D; Murjani K; Singh V
    Prog Mol Biol Transl Sci; 2024; 208():43-58. PubMed ID: 39266187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR: From Prokaryotic Immune Systems to Plant Genome Editing Tools.
    Bandyopadhyay A; Mazumdar S; Yin X; Quick WP
    Adv Exp Med Biol; 2017; 1016():101-120. PubMed ID: 29130156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
    Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
    J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
    Baker C; Hayden MS
    F1000Res; 2020; 9():281. PubMed ID: 32528662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials and promising preclinical applications of CRISPR/Cas gene editing.
    Çerçi B; Uzay IA; Kara MK; Dinçer P
    Life Sci; 2023 Jan; 312():121204. PubMed ID: 36403643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.